Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TRZ 4MMAF+ 4DXd

Next Previous
Drug Profile

TRZ 4MMAF+ 4DXd

Alternative Names: Trastuzumab monomethyl auristatin F-exatecan derivative conjugate therapeutic - CHO Pharma/TE-Meds; TRZ+4MMAF+4DXd; TRZ-4(MMAF+DXd); TRZ4 MMAF+DXd; TRZ4/MMAF/DXd

Latest Information Update: 26 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CHO Pharma; TE-Meds
  • Class Antineoplastics; Camptothecins; Drug conjugates; Immunotoxins; Monoclonal antibodies
  • Mechanism of Action Apoptosis stimulants; DNA topoisomerase I inhibitors; Mitosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Breast cancer

Most Recent Events

  • 19 Apr 2024 Preclinical trials in Breast cancer in USA (Parenteral) prior to April 2024 (TE-Meds pipeline, April 2024)
  • 19 Apr 2024 Pharmacodynamics data from a preclinical trial in Breast cancer released by TE-Meds (TE-Meds pipeline, April 2024)
  • 15 Sep 2023 CHO Pharma and TE-Meds agree to co-develop CHO-TEM antibody drug conjugates

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top